Serum fatty acids and blood pressure

Hypertension

Volumn 27, Issue 2, 1996, Pages 303-307

  Simon, Joel A ^a,b   Fong, Josephine ^b   Bernert Jr , John T ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

blood pressure; diet; fatty acids

Indexed keywords

CHOLESTEROL ESTER; DIHOMO GAMMA LINOLENIC ACID; FATTY ACID; ICOSATRIENOIC ACID; MONOUNSATURATED FATTY ACID; PALMITOLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; FATTY ACID BLOOD LEVEL; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0030022668     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.2.303     Document Type: Article

References (31)

1. Committee on Diet and Health. Food and Nutrition Board, National Research Council. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press; 1989.
2. Willett W. Nutritional Epidemiology. New York, NY: Oxford University Press; 1990.
3. Renaud SC. What is the epidemiologic evidence for the thrombogenic potential of dietary long-chain fatty acids? Am J Clin Nutr. 1992;56:823S.
4. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT Jr, Hulley SB. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol. 1995;142:469-476.
5. Simon JA, Fong J, Bernert JT Jr, Browner WS. Serum fatty acids and the risk of stroke. Stroke. 1995;26:778-782.
6. Sherwin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE Jr. The Multiple Risk Factor Intervention Trial (MRFIT), II: the development of the protocol. Prev Med. 1981;10:402-425.
7. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248:1465-1477.
8. Tillotson JL, Gorder DD, Kassim N. Nutrition data collection in the Multiple Risk Factor Intervention Trial (MRFIT): baseline nutrient intake of a randomized population. J Am Diet Assoc. 1981;78:235-240.
9. Newman TB, Browner WS. In defense of standardized regression coefficients. Epidemiology. 1991;2:383-386.
10. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
11. SAS Institute. SAS Version 6.07, SAS/STAT User's Guide. 4th ed. Cary, NC: SAS Institute; 1989.
12. Oster P, Arab L, Sehellenberg B, Hueck CC, Mordasini R, Schlierf G. Blood pressure and adipose tissue linoleic acid. Res Exp Med (Berl). 1979;175:287-291.
13. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T. Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J. 1982;285:993-996.
14. Wood DA, Butler S, Riemersma RA, Thomson M, Oliver MF. Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men. Lancet. 1984;2:117-121.
15. Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure? Am J Clin Nutr. 1986;44:336-340.
16. Ciocca S, Arca M, Montali A, Fazio S, Bucci A, Angelico F. Lack of association between arterial blood pressure and erythrocyte fatty acid composition in an Italian population sample. Scand J Clin Lab Invest. 1987;47:105-110.
17. Rubba P, Mancini M, Fidanza F, Gautiero G, Salo M, Nikkari T, Elton R, Oliver MF. Adipose tissue fatty acids and blood pressure in middle-aged men from southern Italy. Int J Epidemiol. 1987;16:528-531.
18. Wood DA, Riemersma RA, Butler S, Thomson M, Macintyre C, Elton RA, Oliver MF. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet. 1987;1:177-182.
19. Cambien F, Warnet J-M, Vernier V, Ducimetiere P, Jacqueson A, Flament C, Orssaud G, Richard J-L, Claude J-R. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middleaged men. Am J Epidemiol. 1988;127:75-86.
20. DeBacker G, DeCraene I, Rosseneu M, Vercaemst R, Kornitzer M. Relationship between serum cholesteryl ester composition, dietary habits and coronary risk factors in middle-aged men. Atherosclerosis. 1989;78:237-243.
21. Leng GC, Smith FB, Fowkes FGR, Horrobin DF, Ells K, Morse-Fisher N, Lowe GDO. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids. 1994;51:101-108.
22. Grundy SM. Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am J Clin Nutr. 1994;60(suppl):986S-990S.
23. Kritchevsky D. Stearic acid metabolism and atherogenesis: history. Am J Clin Nutr. 1994;6(suppl):997S-1001S.
24. Schrade W, Boehle E, Biegler R. Humoral changes in arteriosclerosis: investigations on lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood. Lancet. 1960;2:1409-1416.
25. Bucalossi A, Mori S. Fatty acid composition of adipose tissue in ischemic heart disease and stroke. Geront Clin. 1972;14:339-345.
26. Kirkeby K, Ingvaldsen P, Bjerkedal I. Fatty acid composition of serum lipids in men with myocardial infarction. Acta Med Scand. 1972;192:513-519.
27. Boberg M, Vessby B, Croon I.B. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease. Atherosclerosis. 1985;58:49-63.
28. Ciavatti M, Michel G, Dechavanne M. Platelet phospholipid in stroke. Clin Chim Acta. 1978;84:347-351.
29. Nordøy A. Dietary fatty acids, platelets, endothelial cells and coronary heart disease. Acta Med Scand. 1985;701:15-22.
30. Hagenfeldt L, Paasikivi J. Sjögren A. Plasma levels of free polyunsaturated fatty acids in patients with ischemic heart disease. Metabolism. 1973;22:1349-1356.
31. Goodnight SH Jr, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis. 1982;2:87-113.